News

Positron Corp PosiRx 3000-Series Pharmacy Automation Systems

Positron Corp. announced the release of the PosiRx 3000-Series, its latest pharmacy automation systems. The PosiRx 3000-Series are the first systems to automate and encompass the complete...

CardioPET

The next generation of positron emission tomography (PET) imaging agents will herald an age when PET will eclipse single photon emission computed tomography (SPECT) as the “go to” modality for...

UltraSPECT has announced its distribution agreement with PharmaLogic for the sale of UltraSPECT’s cardiac and bone imaging applications. The agreement will enable PharmaLogic to provide...

FDA Approval GE Healthcare's AdreView Nuclear Imaging SPECT systems

GE Healthcare announced the U.S. Food and Drug Administration (FDA) approval of a new indication for AdreView (Iobenguane I 123 Injection), the first and only FDA approved molecular imaging agent...

Nuclear Imaging Choosing Wisely Five Questions Testing PET/SPECT Systems

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) released a list of specific tests that are commonly ordered—but not always necessary — in nuclear medicine and molecular imaging as...

Nuclear Medicine Information Systems LLC (NMIS) and BioDose LLC have been renamed and rebranded as ec2 Software Solutions, company officials announced.

The introduction of hybrid technology — positron emission tomography/computed tomography (PET/CT) and single-photon emission computed tomography (SPECT)/CT -— has revolutionized the imaging world...

August 2, 2012 — According to new research published in the August issue of the Journal of Nuclear Medicine,...

July 13, 2012 — Royal Philips Electronics announced that it has embarked on a five-year joint research and development (R&D) program with the St. Petersburg State Polytechnical University, the...

GE Healthcare introduced the latest addition to its Nuclear Medicine 600 series with a new performance SPECT/CT (single photon emission computed tomography/computed tomography) system, the Optima...

June 8, 2012 — At this year’s SNM Annual Meeting, June 9-13, Philips Healthcare is highlighting its portfolio of nuclear medicine (NM) applications for IntelliSpace Portal, adding to its existing...

May 7, 2012 — Wide Beam Reconstruction (WBR) reduces the required radiopharmaceutical dose and image acquisition time by 50 percent for diagnostic quality myocardial perfusion imaging (MPI) single...

April 27, 2012 - More than 150 molecular imaging professionals gathered last week at the Society of Nuclear Medicine’s third Multimodality Cardiovascular Molecular Imaging Symposium held at the...

January 9, 2012 - GE Healthcare announced the Brivo NM615 has received clearance from the U.S. Food and Drug Administration (FDA). 

November 15, 2011 – The new full iterative technology (FIT) now available on the BrightView XCT uses advanced algorithms for the truest picture possible. New clinical cases show that concurrent...

September 9, 2011 — GE Healthcare announced it has received commitments from more than 100 customers globally for its Alcyone technology. The Alcyone is a nuclear cardiology platform designed to...

June 8, 2011 – GE Healthcare is offering a new fully upgradeable SPECT technology that allows patient dose as low as 50 percent of those of standard nuclear medicine scanning protocols, or the...
June 8, 2011 – Research introduced at the Society of Nuclear Medicine's 58th annual meeting this week may lead to much-needed cardiovascular disease screening for diabetic patients at risk of...

April 22, 2011 – At the Society of Nuclear Medicine’s annual meeting, Philips will highlight several new imaging systems. The meeting will take place June 4-8 in San Antonio, Texas.

SNM's Clinical Trials Network (CTN) last week validated its 100th scanner, an important milestone in CTN's two-and-a-half year history. Scanner validation is an essential component of the CTN...